Annual report pursuant to Section 13 and 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.20.2
3. Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Disaggregated Revenue by Source

The following table presents the Company’s disaggregated revenues by revenue source:

 

   

Year Ended

March 31,

  
    2020     2019  
Product            
Human Care   $ 15,686,000     $ 15,912,000  
Animal Care     2,091,000       1,969,000  
      17,777,000       17,881,000  
Service     1,159,000       1,089,000  
Total   $ 18,936,000     $ 18,970,000  
Property and equipment estimated useful life

Estimated useful asset life by classification is as follows:

 

    Years  
Office equipment     3  
Manufacturing, lab and other equipment     5  
Furniture and fixtures     7  
Schedule of antidilutive shares

. The computation of basic loss per share for the years ended March 31, 2020 and 2019 excludes the potentially dilutive securities summarized in the table below because their inclusion would be anti-dilutive.

 

    March 31,  
    2020     2019  
Common stock to be issued upon vesting of restricted stock units     2,000       4,000  
Common stock to be issued upon exercise of options     378,000       165,000  
Common stock to be issued upon exercise of warrants     468,000       468,000  
Common stock to be issued upon conversion of Series C     17,000       17,000  
Common stock to be issued upon exercise of common stock units (1)     46,000       46,000  
      911,000       695,000  

  

  (1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock